Big News:
FDA is moving from MasterControl to ComplianceQuest.
See Why
Search AgentQ
/
Talk to a Specialist
Loading…
My Dashboard
Inspection Tracker
Warning Letters
Ketdaxandrugs / www.ketdaxandrugs.org
All Warning Letters
Ketdaxandrugs / www.ketdaxandrugs.org
Warning Letter
Open
United States
Issued Jun 23, 2026
Center for Drug Evaluation and Research (CDER)
Watch Company
View Letter
Source: FDA, published letter.
FDA published this warning letter; View Letter opens FDA's copy.
Violations
2
Issue Date
Jun 23, 2026
Product Type
Drugs
Status
Open
Overview
Violations
2
Related Form 483s
0
Related Inspections
0
Letter Details
Firm
Ketdaxandrugs / www.ketdaxandrugs.org
Location
United States
FEI Number
N/A
Country
United States
Issue Date
June 23, 2026
Issuing Office
Center for Drug Evaluation and Research (CDER)
Product Type
Drugs
Status
Open
Subject
Unapproved New Drugs/Misbranded
See the 2 Violations
Ketdaxandrugs / www.ketdaxandrugs.org FDA Warning Letter, June 23, 2026
Talk to a SpecialistTalk to a SpecialistTalk to a Specialist